- $846.18m
- $1.01bn
- $795.43m
- 86
- 46
- 88
- 86
Annual income statement for Astronics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 503 | 445 | 535 | 689 | 795 |
Cost of Revenue | |||||
Gross Profit | 97.1 | 76.3 | 77.6 | 121 | 168 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 603 | 463 | 554 | 692 | 779 |
Operating Profit | -101 | -18 | -18.8 | -3.24 | 16.3 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -112 | -27 | -29.8 | -26.3 | -7.87 |
Provision for Income Taxes | |||||
Net Income After Taxes | -116 | -25.6 | -35.7 | -26.4 | -16.2 |
Net Income Before Extraordinary Items | |||||
Net Income | -116 | -25.6 | -35.7 | -26.4 | -16.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -116 | -25.6 | -35.7 | -26.4 | -16.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.81 | -0.907 | -1.21 | -0.864 | -0.275 |